InfaCare Pharmaceuticals Corporation clinical trials
Acquired by Keenova Therapeutics plc, Sep 25, 2017 · source ↗
The registry lists 8 studies whose lead sponsor is InfaCare Pharmaceuticals Corporation. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Feb 2, 2021.
Before and after it joined Keenova Therapeutics plc
- First submitted before InfaCare Pharmaceuticals Corporation became part of Keenova Therapeutics plc
- 8
- First submitted after InfaCare Pharmaceuticals Corporation became part of Keenova Therapeutics plc
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company8 studies
Something wrong with this grouping? Tell us on the Keenova Therapeutics plc page.
Studies
Recruiting first, then most recently updated. Showing 8 of 8. All Keenova Therapeutics plc studies →
- Follow up Study of Patients Having Participated in Clinical Trial 64,185-204CompletedNCT02000830
Sponsor listed in the registry: InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company · First submitted before InfaCare Pharmaceuticals Corporation became part of Keenova Therapeutics plc
- Stannsoporfin With Light Therapy for Newborn Babies With JaundiceCompletedNCT01887327Phase 2
Sponsor listed in the registry: InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company · First submitted before InfaCare Pharmaceuticals Corporation became part of Keenova Therapeutics plc
- A Safety and Efficacy Trial of Stannsoporfin in Neonates With HyperbilirubinemiaTerminatedNCT00850993Phase 2
Sponsor listed in the registry: InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company · First submitted before InfaCare Pharmaceuticals Corporation became part of Keenova Therapeutics plc
- Efficacy and Safety of Stannsoporfin in NeonatesCompletedNCT02685137Phase 3
Sponsor listed in the registry: InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company · First submitted before InfaCare Pharmaceuticals Corporation became part of Keenova Therapeutics plc
- Compassionate Use of Stanate (TM) [Stannsoporfin]No longer availableNCT00076960
Sponsor listed in the registry: InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company · First submitted before InfaCare Pharmaceuticals Corporation became part of Keenova Therapeutics plc
- Safety and Pharmacology of StanateCompletedNCT00115544Phase 2
Sponsor listed in the registry: InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company · First submitted before InfaCare Pharmaceuticals Corporation became part of Keenova Therapeutics plc
- Long-Term Clinical Follow-Up of Children Enrolled in Stannsoporfin Clinical Trial Protocol No. 64,185-06-2(W)TerminatedNCT02685189
Sponsor listed in the registry: InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company · First submitted before InfaCare Pharmaceuticals Corporation became part of Keenova Therapeutics plc
- Observational Follow-up of Participants From Clinical Trial 64,185-202 (NCT00850993)CompletedNCT02033096
Sponsor listed in the registry: InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company · First submitted before InfaCare Pharmaceuticals Corporation became part of Keenova Therapeutics plc